Bristol Myers Squibb

The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.

Bristol-Myers Squibb Company
Trade name
Bristol Myers Squibb
FormerlyBristol-Myers Company (1887–1989)
Company typePublic
Traded as
  • NYSE: BMY
  • S&P 100 component
  • S&P 500 component
IndustryPharmaceuticals
PredecessorsSquibb Corporation (1858–1989)
Founded1887 (1887)
Founders
Headquarters
Area served
Worldwide
Key people
Revenue US$45.01 billion (2023)
US$8.44 billion (2023)
Net income
US$8.04 billion (2023)
Total assets US$95.16 billion (2023)
Total equity US$29.43 billion (2023)
Number of employees
34,100 (2023)
Websitebms.com
Footnotes / references

Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.

BMS's primary research and development (R&D) sites are located in Lawrence, New Jersey (formerly Squibb, near Princeton), Summit, New Jersey, formerly HQ of Celgene, New Brunswick, New Jersey, Redwood City, California, and Seville in Spain, with other sites in Devens and Cambridge, Massachusetts, Braine-l'Alleud, Belgium, Tokyo, Japan, Hyderabad; Bangalore India and Wirral, United Kingdom. BMS previously had an R&D site in Wallingford, Connecticut (formerly Bristol-Myers).

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.